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We have previously determined that atria1 natriuretic factor (ANF) is a potent inhibitor of steroid secretion 
in cultured bovine zona glomerulosa and fasciculata cells. The present report describes a comparison of 
the effect produced by ANF on aldosterone, deoxycorticosterone and progesterone secretions by zona glo- 
merulosa cells and on cortisol, corticosterone and progesterone secretions by zona fasciculata cells. The 
equipotent inhibitory action of ANF on the stimulated secretion of these steroids in both cell types indicates 
a common site of action prior to progesterone synthesis at which ANF inhibits the steroidogenic pathway. 
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1. INTRODUCTION 
We have previously reported that atria1 
natriuretic factor (ANF) inhibits aldosterone 
(Aldo) and cortisol (F) secretions by cultured 
bovine adrenal cells [l]. Because ANF im- 
munoreactivity was detected in plasma [2], it is 
possible that ANF may be involved in the control 
of adrenal steroid secretion. Therefore, it was im- 
portant to determine the site of action of ANF in 
adrenal regulation. The present studies were per- 
formed to investigate the steroid response of 
cultured bovine glomerulosa and fasciculata cells 
to ANF. These cells were used because they display 
a great response and sensitivity to various stimuli 
such as increased potassium concentration, 
angiotensin II, ACTH, prostaglandin Et, forskolin 
and phorbol ester. 
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3. RESULTS 
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2. MATERIALS AND METHODS 
Primary cultures of bovine adrenal zona 
glomerulosa and zona fasciculata were performed 
as described [1,3]. After a 3-day culture period, the 
cells were incubated for 3 h in 1 ml of culture 
medium supplemented with 0.01% lysozyme, in 
the presence of tested substances. Each drug treat- 
ment was replicated in 4 adjacent plate wells. 
Aldo, deoxycorticosterone (DOC), corticosterone 
(B) and F were determined in the incubating media 
by direct radioimmunoassay, using highly specific 
antibodies [4]. Progesterone (Prog) was measured 
by radioimmunoassay after extraction with 
petroleum ether and separation on miniature 
Sephadex LH-20 columns IS]. Synthetic ANF 
(101-126) [6] was generously supplied by Dr R.F. 
Nutt (Merck, Sharp and Dohme Research, West 
Point, PA); angiotensin II was purchased from 
Peninsula (Belmont, CA); ACTH, prostaglandin 
Er, forskolin and phorbol ester from Sigma. 
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angiotensin II, 10 nM ACTH, 1 PM forskolin, 
1 pM prostaglandin El, 1 PM phorbol ester and 
25.5 mM potassium produced a 6.5, 9, 12, 11, 3, 
and 2.5-fold increase in Aldo production, respec- 
tively. Simultaneous incubation of the cells with 
the maximum inhibitory dose of ANF (10 nM) in- 
hibited the Aldo response to each of the 6 
stimulators. Fig.1 shows that the potency of ANF 
(ED50 30-100 PM) was independent of the 
stimulated agent. 
The experiments shown in fig.2 indicated that 
ANF also equipotently (ED50 20-90 PM) inhibited 
hormone-stimulated secretion in fasciculata cells. 
Addition of 10 nM angiotensin II, 10 nM ACTH 
and 1 PM prostaglandin El, increased F secretion 
18, 12 and g-fold, respectively. However, maximal 
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Fig.1. Aldosterone response of stimulated zona 
glomerulosa cells to different doses of ANF. With 
angiotensin II, ACTH, prostaglandin El, forskolin, 
phorbol ester and potassium the increase of basal Aldo 
secretion (1.0 f 0.1 pmol/106 cells per 3 h) was 6.5, 9, 
12, 11, 3 and 2.5-fold, respectively. In the presence of 
the maximum inhibitvry dose of ANF (10 nM), the 
stimulation was decreased by 40,40,64,45, 55 and 65070, 
respectively. Data are presented as percent of the 
In addition to the inhibition of Aldo and F, 
there was a marked fall in DOC, B and Prog secre- 
tion in these adrenal cell cultures. In the presence 
of 10 nM ANF, the prostaglandin El-stimulated 
Prog secretion was reduced by 56% in zona 
glomerulosa and by 53% in zona fasciculata cells; 
a similar inhibition was observed in DOC and B 
production (table 1). ANF also displayed the same 
potency (EDso 50-100 PM) as inhibitor of pros- 
taglandin El-stimulated production of all steroids 
<tested (fig.3). 
maximum inhibition. Fig.4 shows that ANF inhibits non-competitive- 
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Fig.2. Cortisol response of stimulated zona fasciculata 
cells to different doses of ANF. With angiotensin II, 
ACTH and prostaglandin El the increase of basal F 
secretion (21 f 4 pmol/106 cells per 3 h) was 18, 12 and 
9-fold, respectively. ANF produced its maximum 
inhibitory effect at 10 nM, with a decrease of the 
stimulated F secretion by 18, 22 and 29070, respectively. 
Data are presented as percent of the maximum 
inhibition. Each result is the mean + SE from 2-3 
experiments. 
inhibition of hormone-stimulated F secretion by 
ANF was only between 18 and 29%. 
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Table 1 
Effect of ANF (10 r&l) on prostaglandin Ei (1 PM) stimulated steroid secretion in bovine 
adrenal cell cultures 
Control ANF % change 
Zona glomerulosa 
Progesterone (n = 3) 167 + 54 74 * 2oa -56 
Deoxycorticosterone (n = 5) 77 * 22 35 * lla -55 
Aldosterone (n = 4) 10 + 2.6 3.8 f 0.6= -64 
Zona fasciculata 
Progesterone (n = 3) 97 f 37 46 + 19a -53 
Corticosterone (n = 3) 565 + 90 259 f 44a -54 
Cortisol (n = 3) 191 f 41 135 * 34a -29 
Steroid secretion of cell cultures is expressed in pmol/106 cells per 3 h (mean + SE). In 
glomerulosa cell cultures the basal secretion of Prog, DOC and Aldo was 16 f 3, 18 + 6 and 
1 + 0.1 pmol, respectively. In fasciculata cultures the basal secretion of Prog, B and F was 
11 k 0.5, 19 + 4 and 21 + 4 pmol, respectively. n = number of experiments. ap < 0.05; b p < 
0.01 
ANF CONCENTRATION (nMj 
Fig.3. Progesterone, deoxycorticosterone and aldoster- 
one response of prostaglandin El-stimulated glome- 
rulosa cells (left), and progesterone, corticosterone and 
cortisol response of prostaglandin El-stimulated 
fasciculata cells (right) to different doses of ANF. 
Steroid output is expressed as percent of the maximum 
inhibition. Each result is the mean f SE from 2-3 
experiments. 
ly, hormone-stimulated steroidogenesis. Addition 
of 10 nM ANF markedly reduced the maximum 
Aldo response, without changing the EDsc with 
respect to angiotensin II stimulation. 
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Fig.4. Angiotensin II dose-response curve in the absence 
and presence of ANF (10 nM). Each result is the mean & 
SE from 4 experiments. 
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4. DISCUSSION 
These studies confirm that ANF is a potent in- 
hibitor of steroid secretion of both zona 
glomerulosa and zona fasciculata cells [7-91. The 
observation that ANF was equipotent in reducing 
Aldo, DOC and B secretion in glomerulosa cells 
may indicate that inhibition prior to progesterone 
is the primary site of action of ANF in zona 
glomerulosa cells. This mechanism would also ex- 
plain the results of the experiments noted in fig.4. 
These data indicate that ANF reduces the max- 
imum level of stimulation of Aldo secretion by 
angiotensin II, without altering its potency (EDso), 
which suggests that ANF removes a factor from 
the process of Aldo synthesis. 
It is remarkable that the effect of ANF on Prog 
secretion of both glomerulosa and fasciculata cells 
was nearly identical. By analogy it would appear 
that ANF inhibited steroidogenesis in fasciculata 
cells through the same mechanism as in 
glomerulosa cells. This interpretation is supported 
by the findings that ANF displayed an equivalent 
potency (EDso) in inhibiting the secretion of Prog, 
B and F. However, the suppression of F secretion 
with the maximum inhibitory dose of ANF was on- 
ly l&29% while Prog and B secretions showed a 
more prominent suppression. If ANF acts as an in- 
hibitor of the conversion of pregnenolone to Prog 
in zona fasciculata cells, at least some part of its in- 
hibitory action on F secretion (but not on B and 
Prog secretions) would be obscured by the syn- 
thesis of F through an alternative pathway 
(pregnenolone - 17-OH-pregnenolone - F). This 
explanation is compatible with the view that 
17-OH-pregnenolone is an important intermediate 
in F synthesis [lo]. Alternatively, the inhibition of 
the early biosynthetic pathway by ANF may occur 
prior to pregnenolone formation. In this case the 
different suppression of F and B may be due to the 
possibility that under circumstances when the for- 
mation of early biosynthetic precursors is inhibited 
by ANF, the zona fasciculata utilizes dispropor- 
tionally high amounts of precursor for F synthesis 
at the expense of B. 
In summary, our results indicate that ANF has 
an equipotent inhibitory action on steroid secre- 
tion of both glomerulosa and fasciculata cells in 
vitro. The main site of action of ANF appears to 
be a biosynthetic step prior to Prog formation. The 
significance of these data in the physiological con- 
trol of adrenal steroid secretion remains to be 
evaluated. 
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